Puhlmann Markus — SEC insider filings
SEC reporting owner CIK 1965071. 7 insider filings on record with FilingPulse; latest filed 2026-11-13.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2023-12-14 to 2026-11-13. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 3 filings — 916,425 shares, $363,170 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: purchase of 280,000 shares @ $0.50 ($139,888) in Perspective Therapeutics, Inc., filed 2024-01-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Perspective Therapeutics, Inc. (CATX) | Chief Medical Officer | 7 | 6 legs · 916,425 sh · $363,170 | — | 4 |
Insider filings — Puhlmann Markus
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-13 | 4 | Perspective Therapeutics, Inc. (CATX) | Purchase (P): 6,000 @ $0.83 · Purchase (P): 35,000 @ $0.84 | EDGAR |
| 2026-03-04 | 4 | Perspective Therapeutics, Inc. (CATX) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Perspective Therapeutics, Inc. (CATX) | Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Perspective Therapeutics, Inc. (CATX) | Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
| 2024-01-26 | 4 | Perspective Therapeutics, Inc. (CATX) | Purchase (P): 280,000 @ $0.50 | EDGAR |
| 2023-12-19 | 4 | Perspective Therapeutics, Inc. (CATX) | Purchase (P): 135,006 @ $0.27 · Purchase (P): 60,419 @ $0.26 · Purchase (P): 400,000 @ $0.34 | EDGAR |
| 2023-12-14 | 4 | Perspective Therapeutics, Inc. (CATX) | Grant/award (A): 1,477,619 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1965071 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs